FL LYMPHOMA
Clinical trials for FL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new FL LYMPHOMA trials appear
Sign up with your email to follow new studies for FL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough lymphomas: experimental drug MDX2003 enters human testing
Disease control Recruiting nowThis study tests an experimental drug called MDX2003 in about 180 adults with B-cell lymphomas (like diffuse large B-cell lymphoma or follicular lymphoma) that have returned or not improved after at least two prior treatments. The main goals are to find the safest dose and to see…
Matched conditions: FL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New oral drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests an experimental drug called HH2853 for people with certain types of blood cancer (non-Hodgkin's lymphoma) or advanced solid tumors that have come back or not responded to treatment. The goal is to find the safest dose and see if the drug can shrink tumors. About …
Matched conditions: FL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Haihe Biopharma Co., Ltd. • Aim: Disease control
Last updated Apr 26, 2026 19:36 UTC